Management of bone loss due to endocrine therapy during cancer treatment
Crossref DOI link: https://doi.org/10.1007/s00198-023-06672-3
Published Online: 2023-01-19
Published Print: 2023-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khan, Maryam I. http://orcid.org/0000-0002-8454-0201
Text and Data Mining valid from 2023-01-19
Version of Record valid from 2023-01-19
Article History
Received: 15 November 2022
Accepted: 4 January 2023
First Online: 19 January 2023
Declarations
:
: The author declares no competing interests.